Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alx Oncology Holdings (ALXO) Other Operating Expenses (2019 - 2025)

Alx Oncology Holdings' Other Operating Expenses history spans 2 years, with the latest figure at $479000.0 for Q2 2020.

  • On a quarterly basis, Other Operating Expenses fell 59.3% to $479000.0 in Q2 2020 year-over-year; TTM through Mar 2021 was $479000.0, a 88.08% decrease, with the full-year FY2025 number at $3.2 million, changed N/A from a year prior.
  • Other Operating Expenses hit $479000.0 in Q2 2020 for Alx Oncology Holdings, down from $596000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for ALXO hit a ceiling of $1.2 million in Q2 2019 and a floor of $479000.0 in Q2 2020.